Insider Trading History of Perry Gregory D

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Perry Gregory D since 2011. The trader's CIK number is 1236371. At the time of the last reporting, Perry Gregory D was the Chief Financial Officer of Novelion Therapeutics Inc.. (stock ticker symbol NVLNF). Also see all insider trading activities at Novelion Therapeutics Inc..

Note that in the past PERRY GREGORY D also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Novelion Therapeutics Inc. (NVLN) by Perry Gregory D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 NVLN 0 $0 0 $0 2,393 $0

Yearly summary of insider trading at Immunogen, Inc. (IMGN) by Perry Gregory D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 IMGN 0 $0 18,337 $326,691 18,337 $79,215
2011 IMGN 0 $0 49,998 $626,880 49,998 $215,988


Insider trading activities at 2 companies by Perry Gregory D:

1. Novelion Therapeutics Inc. (NVLN)

2. Immunogen, Inc. (IMGN)

Table 1. Insider trading of Novelion Therapeutics Inc. (NVLN) by Perry Gregory D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-05-09 NVLN Option Ex 2,393 .00 0

Table 2. Insider trading of Immunogen, Inc. (IMGN) by Perry Gregory D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-09-10 IMGN Option Ex 18,337 4.32 79,215
2013-09-10 IMGN Sale 18,337 17.82 326,691
2011-11-15 IMGN Option Ex 8,333 4.32 35,998
2011-11-15 IMGN Sale 8,333 12.58 104,862
2011-10-17 IMGN Sale 8,333 13.40 111,645
2011-10-17 IMGN Option Ex 8,333 4.32 35,998
2011-09-26 IMGN Option Ex 8,333 4.32 35,998
2011-09-26 IMGN Sale 8,333 11.00 91,663
2011-08-15 IMGN Option Ex 8,333 4.32 35,998
2011-08-15 IMGN Sale 8,333 11.05 92,121
2011-07-15 IMGN Option Ex 8,333 4.32 35,998
2011-07-15 IMGN Sale 8,333 15.12 126,019
2011-06-29 IMGN Option Ex 8,333 4.32 35,998
2011-06-29 IMGN Sale 8,333 12.07 100,570

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Perry Gregory D (Chief Financial Officer of Novelion Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.